{
  "total_facts": 16,
  "average_quality_score": 86.875,
  "estimated_precision": 1.0,
  "results": [
    {
      "fact": {
        "drug_name": "sertraline",
        "condition_name": "major depressive disorder",
        "relation": "FIRST_LINE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "Lancet",
        "section": "Summary",
        "span": "Sertraline might be the best choice when starting treatment for moderate to severe major depression in adults because it has the most favourable balance between benefits, acceptability, and acquisition cost.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "multiple-treatments meta-analysis",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "escitalopram",
        "condition_name": "major depressive disorder",
        "relation": "FIRST_LINE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "Lancet",
        "section": "Summary",
        "span": "Interpretation Clinically important differences exist between commonly prescribed antidepressants for both efficacy and acceptability in favour of escitalopram and sertraline.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "multiple-treatments meta-analysis",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "paroxetine",
        "condition_name": "major depressive disorder",
        "relation": "EQUIVALENT_TO",
        "outcome": "response rate",
        "side_effects": [],
        "effect_size": "77/199 vs 102/207",
        "confidence_interval": "95% CI 1.04-2.28",
        "source_id": "Lancet",
        "section": "Role of the funding source",
        "span": "Paroxetine showed a response rate of 77/199 compared to 102/207 with an OR of 1.54 (95% CI 1.04-2.28) in patients with major depressive disorder.",
        "confidence": 1.0,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "RCT",
        "sample_size": 406,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 80.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 80,
          "likely_correct": true,
          "issues": [
            "Span doesn't contain typical EQUIVALENT_TO language"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "reboxetine",
        "condition_name": "major depressive disorder",
        "relation": "SUPERIOR_TO",
        "outcome": "response rate",
        "side_effects": [],
        "effect_size": "145/227 vs 110/224",
        "confidence_interval": "95% CI 1.01-2.93",
        "source_id": "Lancet",
        "section": "Role of the funding source",
        "span": "Reboxetine demonstrated a superior response rate of 145/227 compared to 110/224 with an OR of 1.72 (95% CI 1.01-2.93) in major depressive disorder.",
        "confidence": 1.0,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "RCT",
        "sample_size": 451,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "sertraline",
        "condition_name": "major depressive disorder",
        "relation": "EQUIVALENT_TO",
        "outcome": "response rate",
        "side_effects": [],
        "effect_size": "139/200 vs 136/200",
        "confidence_interval": "95% CI 0.61-1.42",
        "source_id": "Lancet",
        "section": "Role of the funding source",
        "span": "Sertraline showed a response rate of 139/200 compared to 136/200 with an OR of 0.93 (95% CI 0.61-1.42) in patients with major depressive disorder.",
        "confidence": 1.0,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "RCT",
        "sample_size": 615,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 80.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 80,
          "likely_correct": true,
          "issues": [
            "Span doesn't contain typical EQUIVALENT_TO language"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "venlafaxine",
        "condition_name": "major depressive disorder",
        "relation": "SUPERIOR_TO",
        "outcome": "response rate",
        "side_effects": [],
        "effect_size": "14/34 vs 48/77",
        "confidence_interval": "95% CI 0.19-0.96",
        "source_id": "Lancet",
        "section": "results",
        "span": "Venlafaxine showed a superior response rate compared to its comparator with a response rate of 14/34 vs 48/77 and an odds ratio of 0.42 (95% CI 0.19-0.96).",
        "confidence": 1.0,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "meta-analysis",
        "sample_size": 111,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "fluvoxamine",
        "condition_name": "major depressive disorder",
        "relation": "EQUIVALENT_TO",
        "outcome": "response rate",
        "side_effects": [],
        "effect_size": "31/109 vs 33/108",
        "confidence_interval": "95% CI 0.50-1.62",
        "source_id": "Lancet",
        "section": "results",
        "span": "Fluvoxamine was found to be equivalent to citalopram in terms of response rate with 31/109 vs 33/108 and an odds ratio of 0.90 (95% CI 0.50-1.62).",
        "confidence": 1.0,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "meta-analysis",
        "sample_size": 217,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "fluoxetine",
        "condition_name": "major depressive disorder",
        "relation": "EQUIVALENT_TO",
        "outcome": "response rate",
        "side_effects": [],
        "effect_size": "83/141 vs 83/143",
        "confidence_interval": "95% CI 0.64-1.66",
        "source_id": "Lancet",
        "section": "results",
        "span": "Fluoxetine was found to be equivalent to its comparator in terms of response rate with 83/141 vs 83/143 and an odds ratio of 1.03 (95% CI 0.64-1.66).",
        "confidence": 1.0,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "meta-analysis",
        "sample_size": 284,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "escitalopram",
        "condition_name": "major depressive disorder",
        "relation": "FIRST_LINE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "Lancet",
        "section": "discussion",
        "span": "the most important clinical implication of the results is that escitalopram and sertraline might be the best choice when starting a treatment for moderate to severe major depression because they have the best possible balance between efficacy and acceptability.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "sertraline",
        "condition_name": "major depressive disorder",
        "relation": "FIRST_LINE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "Lancet",
        "section": "discussion",
        "span": "the most important clinical implication of the results is that escitalopram and sertraline might be the best choice when starting a treatment for moderate to severe major depression because they have the best possible balance between efficacy and acceptability.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "mirtazapine",
        "condition_name": "major depressive disorder",
        "relation": "SUPERIOR_TO",
        "outcome": "response",
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "Lancet",
        "section": "discussion",
        "span": "In terms of response, mirtazapine, escitalopram, venlafaxine, and sertraline were more efficacious than duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 70.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 70,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span",
            "Span doesn't contain typical SUPERIOR_TO language"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "venlafaxine",
        "condition_name": "major depressive disorder",
        "relation": "SUPERIOR_TO",
        "outcome": "response",
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "Lancet",
        "section": "discussion",
        "span": "In terms of response, mirtazapine, escitalopram, venlafaxine, and sertraline were more efficacious than duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 70.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 70,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span",
            "Span doesn't contain typical SUPERIOR_TO language"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "sertraline",
        "condition_name": "major depressive disorder",
        "relation": "SUPERIOR_TO",
        "outcome": "response",
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "Lancet",
        "section": "discussion",
        "span": "In terms of response, mirtazapine, escitalopram, venlafaxine, and sertraline were more efficacious than duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 70.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 70,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span",
            "Span doesn't contain typical SUPERIOR_TO language"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "escitalopram",
        "condition_name": "major depressive disorder",
        "relation": "SUPERIOR_TO",
        "outcome": "response",
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "Lancet",
        "section": "discussion",
        "span": "In terms of response, mirtazapine, escitalopram, venlafaxine, and sertraline were more efficacious than duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 70.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 70,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span",
            "Span doesn't contain typical SUPERIOR_TO language"
          ]
        }
      }
    },
    {
      "fact": {
        "drug_name": "reboxetine",
        "condition_name": "major depressive disorder",
        "relation": "CONTRAINDICATED_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "Lancet",
        "section": "discussion",
        "span": "Reboxetine should not be used as a routine first-line acute treatment for major depression.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 100.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 100,
          "likely_correct": true,
          "issues": []
        }
      }
    },
    {
      "fact": {
        "drug_name": "reboxetine",
        "condition_name": "major depressive disorder",
        "relation": "ASSOCIATED_WITH_SE",
        "outcome": null,
        "side_effects": [
          "poor acceptability"
        ],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "Lancet",
        "section": "discussion",
        "span": "In terms of acceptability, reboxetine was the least tolerated agent among the 12 antidepressants and was significantly less effective than all the other 11 drugs.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "quality_score": 90.0,
      "likely_correct": true,
      "method_results": {
        "heuristic": {
          "quality_score": 90,
          "likely_correct": true,
          "issues": [
            "Condition not explicitly mentioned in span"
          ]
        }
      }
    }
  ]
}